BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 28178645)

  • 1. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.
    Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS
    Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.
    Wang J; Su X; Yang L; Qiao F; Fang Y; Yu L; Yang Q; Wang Y; Yin Y; Chen R; Hong Z
    Int J Cancer; 2016 Jun; 138(11):2688-99. PubMed ID: 26756887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
    Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
    Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery.
    Su X; Fan Y; Yang L; Huang J; Qiao F; Fang Y; Wang J
    J Transl Med; 2018 Dec; 16(1):347. PubMed ID: 30537999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
    Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.
    Papadaki MA; Aggouraki D; Vetsika EK; Xenidis N; Kallergi G; Kotsakis A; Georgoulias V
    Anticancer Res; 2021 Feb; 41(2):661-670. PubMed ID: 33517270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CARD9 prevents lung cancer development by suppressing the expansion of myeloid-derived suppressor cells and IDO production.
    Qu J; Liu L; Xu Q; Ren J; Xu Z; Dou H; Shen S; Hou Y; Mou Y; Wang T
    Int J Cancer; 2019 Oct; 145(8):2225-2237. PubMed ID: 31008530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Mobilization and Functional Characterization of Nonhuman Primate Monocytic Myeloid-Derived Suppressor Cells.
    Zahorchak AF; Ezzelarab MB; Lu L; Turnquist HR; Thomson AW
    Am J Transplant; 2016 Feb; 16(2):661-71. PubMed ID: 26372923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic DNA vaccine targeting Foxp3
    Namdar A; Mirzaei R; Memarnejadian A; Boghosian R; Samadi M; Mirzaei HR; Farajifard H; Zavar M; Azadmanesh K; Elahi S; Noorbakhsh F; Rezaei A; Hadjati J
    Cancer Immunol Immunother; 2018 Mar; 67(3):367-379. PubMed ID: 29124314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21a in exosomes from Lewis lung carcinoma cells accelerates tumor growth through targeting PDCD4 to enhance expansion of myeloid-derived suppressor cells.
    Zhang X; Li F; Tang Y; Ren Q; Xiao B; Wan Y; Jiang S
    Oncogene; 2020 Oct; 39(40):6354-6369. PubMed ID: 32855524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host.
    Song G; Zhang Y; Tian J; Ma J; Yin K; Xu H; Wang S
    Front Immunol; 2021; 12():649020. PubMed ID: 33717204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer.
    Liu D; You M; Xu Y; Li F; Zhang D; Li X; Hou Y
    Int Immunopharmacol; 2016 Oct; 39():265-272. PubMed ID: 27497194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells.
    Ren W; Zhang X; Li W; Feng Q; Feng H; Tong Y; Rong H; Wang W; Zhang D; Zhang Z; Tu S
    Sci Rep; 2020 May; 10(1):8056. PubMed ID: 32415175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.